moxifloxacin has been researched along with Bronchitis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broens, A; Collignon, N | 1 |
| Macklin-Doherty, A; Wilson, R | 1 |
| Cheng, TO | 1 |
| Wilson, R | 1 |
| Brosa, M; Miravitlles, M; Molina, J | 1 |
| File, T; Landen, H; Möller, M; Schaberg, T; Stauch, K | 1 |
| Ballin, I; Bassaris, HP; Deppermann, KM; Kubin, R; Leophonte, P; Schreurs, AJ; Sommerauer, B; Torres, A; Wilson, R | 1 |
| Aneiro, L; Chodosh, S; Church, D; DeAbate, CA; Haverstock, D | 1 |
| Busch, W; Lorenz, J; Thate-Waschke, IM | 1 |
| Ball, P | 1 |
| Church, D; DeAbate, CA; Heyd, A; Mathew, CP; Warner, JH | 1 |
| Kirch, W; Siepmann, M | 1 |
| Cobos, A; Kubin, R; Miravitlles, M; Ros, F; Tillotson, G | 1 |
| Garau, J; Lode, H | 1 |
3 review(s) available for moxifloxacin and Bronchitis
| Article | Year |
|---|---|
The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines | 2012 |
[Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].
Topics: Anti-Bacterial Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Comorbidity; Double-Blind Method; Drug Evaluation; Fluoroquinolones; Forced Expiratory Volume; Humans; Middle Aged; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Treatment Outcome | 2007 |
Improving care for patients with respiratory tract infections.
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Patient Satisfaction; Pneumonia; Quality of Health Care; Quinolines; Sinusitis | 2002 |
4 trial(s) available for moxifloxacin and Bronchitis
| Article | Year |
|---|---|
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Bronchitis; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines | 1999 |
Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome | 2000 |
The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines | 2000 |
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Treatment Outcome | 2001 |
8 other study(ies) available for moxifloxacin and Bronchitis
| Article | Year |
|---|---|
[Moxiflaxin and iris transillumination].
Topics: Acute Disease; Adult; Bronchitis; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Moxifloxacin; Pigment Epithelium of Eye | 2016 |
Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bronchitis; Chemical and Drug Induced Liver Injury; Europe; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Safety-Based Drug Withdrawals; Sinusitis; Stevens-Johnson Syndrome | 2009 |
What is a MOSAIC study?
Topics: Abbreviations as Topic; Aza Compounds; Bronchitis; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Quinolines | 2004 |
MOSAIC acronym.
Topics: Acute Disease; Administration, Oral; Aza Compounds; Bronchitis; Chronic Disease; Double-Blind Method; Fluoroquinolones; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Tablets; Terminology as Topic | 2004 |
Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bronchitis; Family Practice; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Moxifloxacin; Product Surveillance, Postmarketing; Quinolines | 2006 |
[Therapy study of acute exacerbated chronic bronchitis. Quinolone rapidly improves cough and chest pain. BRONCHIMOX Study Group].
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chest Pain; Chronic Disease; Cough; Drug Administration Schedule; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Treatment Outcome | 2000 |
Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Streptococcus pneumoniae | 2000 |
Drug Points: tachycardia associated with moxifloxacin.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Aza Compounds; Bronchitis; Fluoroquinolones; Headache; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Tachycardia | 2001 |